-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Barinthus Biotherapeutics plc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
- Barinthus Biotherapeutics plc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$3K, a 99.5% increase year-over-year.
- Barinthus Biotherapeutics plc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$867K, a 79.7% increase year-over-year.
- Barinthus Biotherapeutics plc. annual Income Tax Expense (Benefit) for 2023 was -$3.08M, a 31.2% increase from 2022.
- Barinthus Biotherapeutics plc. annual Income Tax Expense (Benefit) for 2022 was -$4.47M, a 15868% decline from 2021.
- Barinthus Biotherapeutics plc. annual Income Tax Expense (Benefit) for 2021 was -$28K, a 129% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)